or Try an Advanced Search...

    Technical Analysis for OPTN - OptiNose, Inc.

    Grade Last Price % Change Price Change
    F 0.37 8.32% 0.03
    OPTN closed up 8.32 percent on Wednesday, November 20, 2024, on 1.96 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical OPTN trend table...
    Date Alert Name Type % Chg
    Calm After Storm Range Contraction 0.00%
    Wide Range Bar Range Expansion 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    New 52 Week Low Weakness 0.00%
    Outside Day Range Expansion 0.00%
    Wide Bands Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    New 52 Week Closing Low Bearish 8.32%
    Volume Surge Other 8.32%
    Older End-of-Day Signals for OPTN ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 16 hours ago
    Outside Day about 16 hours ago
    Up 10% about 16 hours ago
    Up 1 ATR about 16 hours ago
    Up 5% about 16 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    OPTN Chart by TradingView
    Basic chart:

    Profile

    OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Clinical Medicine Pharmaceutical Disease Organ Systems Inflammation Allergy Respiratory Therapy Polyp Sinus Glucocorticoids Chronic Rhinosinusitis Corticosteroid Sinusitis Fluticasone Nasal Polyps Nasal Spray

    Is OPTN a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 OptiNose, Inc. (NASDAQ:OPTN) Just Reported, And Analysts Assigned A US$3.50 Price Target
    Nov 14 OptiNose Third Quarter 2024 Earnings: EPS: US$0.002 (vs US$0.083 loss in 3Q 2023)
    Nov 13 OptiNose Inc (OPTN) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Revised Guidance
    Nov 13 Q3 2024 OptiNose Inc Earnings Call
    Nov 12 OptiNose, Inc. (OPTN) Q3 2024 Earnings Call Transcript
    Nov 12 OptiNose, Inc. 2024 Q3 - Results - Earnings Call Presentation
    Nov 12 OptiNose (OPTN) Reports Break-Even Earnings for Q3
    Nov 12 OptiNose gives mixed
    Nov 12 Optinose Reports Third Quarter 2024 Financial Results and Recent Operational Highlights
    Nov 12 Earnings Scheduled For November 12, 2024
    See more OPTN news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.1
    52 Week Low 0.321
    Average Volume 671,617
    200-Day Moving Average 1.08
    50-Day Moving Average 0.70
    20-Day Moving Average 0.63
    10-Day Moving Average 0.54
    Average True Range 0.07
    RSI (14) 24.81
    ADX 31.9
    +DI 17.41
    -DI 38.67
    Chandelier Exit (Long, 3 ATRs) 0.60
    Chandelier Exit (Short, 3 ATRs) 0.53
    Upper Bollinger Bands 0.94
    Lower Bollinger Band 0.33
    Percent B (%b) 0.07
    BandWidth 96.58
    MACD Line -0.10
    MACD Signal Line -0.06
    MACD Histogram -0.0369
    Fundamentals Value
    Market Cap 41.22 Million
    Num Shares 112 Million
    EPS -0.38
    Price-to-Earnings (P/E) Ratio -0.97
    Price-to-Sales 2.09
    Price-to-Book 24.26
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.58
    Resistance 3 (R3) 0.59 0.53 0.54
    Resistance 2 (R2) 0.53 0.47 0.52 0.53
    Resistance 1 (R1) 0.45 0.44 0.49 0.44 0.52
    Pivot Point 0.38 0.38 0.40 0.38 0.38
    Support 1 (S1) 0.30 0.33 0.34 0.30 0.21
    Support 2 (S2) 0.24 0.30 0.24 0.20
    Support 3 (S3) 0.16 0.24 0.19
    Support 4 (S4) 0.15